As you know, dry eye is a growing problem in the US and worldwide.
With over $1 billion in OTC dry eye products sold annually at national retailers in the US, OPTASE® has entered the market with an aggressive wholesale price structure allowing OD practices to increase patient compliance, increase practice revenue, offer the most advanced molecules and delivery systems to patients by stocking products in practice.
Please fill out the following information and the OPTASE® team will be in touch.
